TABLE 5.
Acute Preoperative Opiate Use | PLIF/TLIF With 5-year Follow-up (N = 3291) | |||
---|---|---|---|---|
Adjusted Odds Ratio* | (97.5% Confidence Interval) | P | ||
Tramadol | 1.09 | 0.78 | 1.49 | 0.60 |
Rocodone | 1.10 | 0.89 | 1.35 | 0.38 |
Oxycodone | 1.07 | 0.81 | 1.40 | 0.64 |
Hydromorphone | 2.88 | 1.49 | 5.32 | <0.01 |
ER Oxycodone | 1.65 | 0.64 | 3.76 | 0.26 |
Subacute Preoperative Opiate Use | Adjusted Odds Ratio* | (97.5% Confidence Interval) | P | |
Tramadol | 1.27 | 0.81 | 1.92 | 0.28 |
Hydrocodone | 0.90 | 0.70 | 1.14 | 0.39 |
Oxycodone | 1.11 | 0.74 | 1.63 | 0.60 |
Hydromorphone | 4.05 | 1.20 | 12.29 | 0.02 |
ER Oxycodone | 1.44 | 0.32 | 4.66 | 0.58 |
Chronic Preoperative Opiate Use | Adjusted Odds Ratio* | (97.5% Confidence Interval) | P | |
Tramadol | 1.48 | 0.90 | 2.33 | 0.11 |
Hydrocodone | 0.95 | 0.73 | 1.21 | 0.66 |
Oxycodone | 1.27 | 0.83 | 1.90 | 0.25 |
Hydromorphone | 13.97 | 2.50 | 53.48 | <0.01 |
ER oxycodone | 0.85 | 0.11 | 5.13 | 0.88 |
Multivariate logistic regression controlling for multilevel surgery, patient age, gender and Charlson Comorbidity index.
ER indicates extended release; PLIF/TLIF, posterior/transforaminal lumbar interbody fusion.